An Official Website of the United States Government
Company Information:
Name:
CUMBERLAND PHARMACEUTICALS, INC.
Address:
CUMBERLAND PHARMACEUTICALS INC.
2525 WEST END AVE, STE 950
NASHVILLE, TN 37203
2525 WEST END AVE, STE 950
NASHVILLE, TN 37203
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
High Purity Amphotericin B: A Safer Antimycotic in AIDS
Award Year / Program / Phase:
2005 / STTR / Phase I
Agency:
HHS
Research Institution:
UNIVERSITY OF MISSISSIPPI
Abstract:
DESCRIPTION (provided by applicant): Cumberland Pharmaceuticals and the University of Mississippi Mycotic Research Centers' long-term goal will be to improve anti-fungal pharmacotherapy particularly for patients with human immunodeficiency infections (HIV).
We are jointly developing a high purity… More
Radioprotection by use of Topical Lithium Formulations
Award Year / Program / Phase:
2009 / STTR / Phase I
Agency:
HHS
Research Institution:
VANDERBILT UNIVERSITY
Abstract:
DESCRIPTION (provided by applicant): Roughly 500,000 cancer patients are treated with radiotherapy each year. Acute and late sequelae of radiotherapy have a negative impact upon the quality of life of cancer survivors. These sequelae include proctitis, cys
titis, esophageal stricture, cutaneous… More
Mannan, A Potential Therapeutic for Asthma
Award Year / Program / Phase:
2009 / STTR / Phase I
Agency:
HHS
Research Institution:
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
Abstract:
DESCRIPTION (provided by applicant): The long-term goal of this application is to develop mannan derived from Baker's yeast as asthma therapy. The limitations of currently available immunomodulators are their toxicity at higher doses and the lack of benefi
cial effect on airway smooth muscle (ASM)… More